Clinical-stage Biotech Firms Advance Key Pipelines Amid Renewed Sector InflowsGlobal Report·Aug 28 at 10:12 AMCGEM-0.32%SILO-2.04%
Cullinan Therapeutics CSO Jennifer Michaelson disposes of 30,000 common shares worth $607,800PUBT·Aug 14 at 09:04 PMCGEM-0.32%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Aug 13 at 12:05 PMABEO+1.18%NRC+1.32%
Show Me The Money: Did You Miss CGEM's Rally? Here's What Comes Nextrttnews·Aug 13 at 11:26 AMCGEM-0.32%
Cullinan Reports Positive Phase 3 Zipalertinib Lung Cancer DataTip Ranks·Aug 13 at 10:35 AMCGEM-0.32%
Cullinan Therapeutics, Inc. $CGEM Shares Bought by The Manufacturers Life Insurance CompanyMarket Beat·Aug 13 at 08:42 AMCGEM-0.32%MFC-0.56%
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesMarket Beat·Aug 13 at 06:44 AMCGEM-0.32%
Zipalertinib Plus Chemotherapy Meets Primary Endpoint of Progression-Free Survival in Planned Interim Analysis of Phase 3 REZILIENT3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer | CGEM Stock NewsStockTitan·Aug 12 at 03:30 PMCGEM-0.32%
Biotech Stocks At 52-Week Highs - ALMR +30% On Q2 Reports, DYN, CGEM, DXCM, CAHrttnews·Aug 12 at 07:46 AMDXCM-2.02%DYN-2.69%
Cullinan Therapeutics (NASDAQ:CGEM) Issues Quarterly Earnings ResultsMarket Beat·Aug 8 at 03:11 AMCGEM-0.32%
